# Immix Biopharma, Inc.: filings

IMMX · Nasdaq · CIK 1873835 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/immx.md) · [Financials](/companies/immx/financials.md) · [Filings](/companies/immx/filings.md) · [Insiders](/companies/immx/insiders.md)

## Reports and events: 68 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 81, 8-K 33, 10-Q 14, 3 12, 424B5 9, CORRESP 9, DEFA14A 6, UPLOAD 6, 10-K 5, DEF 14A 5, EFFECT 5, FWP 5, S-8 5, SCHEDULE 13G/A 5, ARS 4, S-1/A 4, S-3 4, SCHEDULE 13G 4, 4/A 3, SC 13G 3, SEC STAFF LETTER 3, 10-K/A 2, DRS 2, S-1 2, SC 13G/A 2, 10-Q/A 1, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D 1, DRSLTR 1, RW 1, RW WD 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 17:10 ET | [8-K](/filings/0001493152-26-045143.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045143 |
| 2026-09-29 | 07:00 ET | [8-K](/filings/0001493152-26-044761.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-044761 |
| 2026-08-07 | 17:05 ET | [10-Q](/filings/0001493152-26-036643.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036643 |
| 2026-07-20 | 06:05 ET | [8-K](/filings/0001493152-26-033829.md) | 8.01 Other events | 0001493152-26-033829 |
| 2026-05-29 | 17:10 ET | [8-K](/filings/0001493152-26-026431.md) | 5.07 Shareholder vote results | 0001493152-26-026431 |
| 2026-05-21 | 17:28 ET | [8-K](/filings/0001493152-26-024872.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024872 |
| 2026-05-21 | 06:04 ET | [8-K](/filings/0001493152-26-024707.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024707 |
| 2026-05-07 | 17:17 ET | [10-Q](/filings/0001493152-26-021764.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021764 |
| 2026-04-06 | 16:37 ET | [DEF 14A](/filings/0001493152-26-015320.md) | Proxy statement, period 2026-04-06 | 0001493152-26-015320 |
| 2026-03-30 | 17:39 ET | [8-K](/filings/0001493152-26-013663.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013663 |
| 2026-03-27 | 17:28 ET | [10-K/A](/filings/0001493152-26-013298.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-013298 |
| 2026-03-25 | 17:23 ET | [8-K](/filings/0001493152-26-012721.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-012721 |
| 2026-03-25 | 17:19 ET | [10-K](/filings/0001493152-26-012714.md) | Annual report, period 2025-12-31 | 0001493152-26-012714 |
| 2025-12-08 | 17:30 ET | [8-K](/filings/0001493152-25-026697.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-026697 |
| 2025-12-08 | 06:15 ET | [8-K](/filings/0001493152-25-026500.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026500 |
| 2025-11-26 | 17:10 ET | [8-K](/filings/0001493152-25-025182.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025182 |
| 2025-11-07 | 17:25 ET | [10-Q](/filings/0001493152-25-021325.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021325 |
| 2025-09-08 | 16:05 ET | [8-K](/filings/0001493152-25-012804.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-012804 |
| 2025-08-08 | 17:28 ET | [10-Q](/filings/0001641172-25-022829.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022829 |
| 2025-06-23 | 17:01 ET | [8-K](/filings/0001641172-25-016120.md) | 5.07 Shareholder vote results | 0001641172-25-016120 |
| 2025-06-03 | 15:00 ET | [8-K](/filings/0001641172-25-013417.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-013417 |
| 2025-05-19 | 17:23 ET | [10-Q/A](/filings/0001641172-25-011519.md) | Quarterly report, amended, period 2025-03-31 | 0001641172-25-011519 |
| 2025-05-19 | 17:19 ET | [10-K/A](/filings/0001641172-25-011513.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-011513 |
| 2025-05-08 | 16:30 ET | [10-Q](/filings/0001641172-25-009280.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009280 |
| 2025-04-30 | 17:49 ET | [DEF 14A](/filings/0001641172-25-006711.md) | Proxy statement, period 2025-04-29 | 0001641172-25-006711 |
| 2025-03-25 | 18:16 ET | [10-K](/filings/0001641172-25-000387.md) | Annual report, period 2024-12-31 | 0001641172-25-000387 |
| 2024-11-12 | 16:30 ET | [10-Q](/filings/0001493152-24-044787.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044787 |
| 2024-08-12 | 17:16 ET | [10-Q](/filings/0001493152-24-031358.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031358 |
| 2024-07-26 | 09:30 ET | [8-K](/filings/0001493152-24-029174.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029174 |
| 2024-07-22 | 21:20 ET | [8-K](/filings/0001493152-24-028595.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-028595 |
| 2024-06-14 | 17:30 ET | [8-K](/filings/0001493152-24-023947.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-023947 |
| 2024-05-20 | 17:27 ET | [8-K](/filings/0001493152-24-020785.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-020785 |
| 2024-05-09 | 16:27 ET | [10-Q](/filings/0001493152-24-018458.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018458 |
| 2024-04-29 | 17:26 ET | [DEF 14A](/filings/0001493152-24-017060.md) | Proxy statement, period 2024-04-29 | 0001493152-24-017060 |
| 2024-03-29 | 16:05 ET | [10-K](/filings/0001493152-24-011975.md) | Annual report, period 2023-12-31 | 0001493152-24-011975 |
| 2024-02-06 | 09:09 ET | [8-K](/filings/0001493152-24-005043.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-005043 |
| 2024-02-05 | 16:37 ET | [8-K](/filings/0001493152-24-004933.md) | 8.01 Other events | 0001493152-24-004933 |
| 2023-11-13 | 20:24 ET | [10-Q](/filings/0001493152-23-040182.md) | Quarterly report, period 2023-09-30 | 0001493152-23-040182 |
| 2023-08-30 | 16:15 ET | [SC 13D](/filings/0001068238-23-000182.md) | Ownership report, active investor | 0001068238-23-000182 |
| 2023-08-22 | 16:05 ET | [8-K](/filings/0001493152-23-029822.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-029822 |
| 2023-08-11 | 16:30 ET | [10-Q](/filings/0001493152-23-027844.md) | Quarterly report, period 2023-06-30 | 0001493152-23-027844 |
| 2023-07-14 | 17:26 ET | [8-K](/filings/0001493152-23-024626.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-024626 |
| 2023-06-08 | 06:05 ET | [8-K](/filings/0001493152-23-020507.md) | 5.07 Shareholder vote results | 0001493152-23-020507 |
| 2023-05-12 | 17:01 ET | [10-Q](/filings/0001493152-23-016721.md) | Quarterly report, period 2023-03-31 | 0001493152-23-016721 |
| 2023-04-25 | 16:52 ET | [DEF 14A](/filings/0001493152-23-013537.md) | Proxy statement, period 2023-04-25 | 0001493152-23-013537 |
| 2023-03-27 | 16:15 ET | [10-K](/filings/0001493152-23-009091.md) | Annual report, period 2022-12-31 | 0001493152-23-009091 |
| 2023-03-22 | 08:42 ET | [8-K](/filings/0001493152-23-008484.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-008484 |
| 2023-03-13 | 06:05 ET | [8-K/A](/filings/0001493152-23-007317.md) | 7.01 Regulation FD disclosure | 0001493152-23-007317 |
| 2023-03-13 | 21:48 ET | [8-K](/filings/0001493152-23-007312.md) | 1.01 Entry into a material agreement | 0001493152-23-007312 |
| 2023-01-18 | 17:07 ET | [8-K](/filings/0001493152-23-001795.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-23-001795 |

Page 1 of 2. [Older](/companies/immx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.